Formation Bio
Formation Bio is a tech-driven, AI-native pharmaceutical company focused on accelerating drug development and bringing new treatments to patients faster and more efficiently. They leverage a proprietary AI-native platform to improve efficiency across the drug development lifecycle, from drug selection to clinical trials. The company acquires clinical-stage assets and applies its technology and expertise to advance them through key value inflection points, aiming to realize greater value per program and provide earlier access to treatments. Their multidisciplinary team comprises experts in drug selection, drug development, and technology, with a collective experience in over 45 approved drugs. Formation Bio targets critical unmet patient needs across various therapeutic areas, addressing the bottleneck in drug development where costs have increased exponentially despite scientific advancements.
Formation Bio
Formation Bio is a tech-driven, AI-native pharmaceutical company focused on accelerating drug development and bringing new treatments to patients faster and more efficiently. They leverage a proprietary AI-native platform to improve efficiency across the drug development lifecycle, from drug selection to clinical trials. The company acquires clinical-stage assets and applies its technology and expertise to advance them through key value inflection points, aiming to realize greater value per program and provide earlier access to treatments. Their multidisciplinary team comprises experts in drug selection, drug development, and technology, with a collective experience in over 45 approved drugs. Formation Bio targets critical unmet patient needs across various therapeutic areas, addressing the bottleneck in drug development where costs have increased exponentially despite scientific advancements.